Macular Degeneration : Drugs
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Drugs could include:
|
Bevacizumab is a cancer medicine that interferes with the growth of cancer cells and
slows their growth and spread in the body.
|
|
Antineoplastic agent; a recombinant humanized monoclonal antibody.
|
|
Pegaptanib decreases the level of a protein that affects the cells of the eye. This protein
can cause swelling and blood vessel changes that lead to macular degeneration and blindness.
|
|
Polyethylene glycol (PEG)-conjugated, modified synthetic RNA oligonucleotide and aptamer; selective vascular endothelial growth factor (VEGF) antagonist.
|
|
Ranibizumab is made from a human antibody fragment. It works by keeping new blood
vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In
people with a certain type of eye disease, new blood vessels grow under the retina where they
leak blood and fluid. This is known as the "wet form" of macular degeneration.
|
|
Recombinant humanized immunoglobulin G 1 kappa (IgG 1 kappa) monoclonal antibody fragment; a vascular endothelial growth factor A (VEGF-A) antagonist.
|
|
Verteporfin works by enhancing the eye's sensitivity to light. Verteporfin affects
abnormal blood vessels in the eye.
|
|
Photosensitizing agent activated by low-intensity laser light; synthetic benzoporphyrin derivative.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.